Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 7, 2004, Pages 367-372

  Pistos, C ^a,b   Michalea, S ^a   Kalovidouris, M ^a   Kontopoulos, G ^b   Georgarakis, M ^c  

^a Integrated Laboratory Services   (Greece)

^b Department of Cardiology ^*  (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Bioequivalence; Cefuroxime axetil; HPLC

Indexed keywords

CEFUROXIME AXETIL; ZINADOL;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; EUROPEAN UNION; FEMALE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; VOLUNTEER;

EID: 3242813755     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42367     Document Type: Article

References (22)

1. Al-Said MS, Al-Khamis KI, Niazy EM, El-Sayed YM, Rashood KA, Al-Bella S, Al-Yamani MA, Al-Najjar TA, Alam SM, Dham R, Qumaruazaman QZ 2000 Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzine and Zinnat) in healthy human volunteers. Biopharm Drug Dispos 21: 205-210
2. Barza M, Melethil S, Berger S, Ernst EC 1976 Comparative pharmacokinetics of cefamandole, cephapirin and cephalothin in healthy subjects and effect of repeated dosing. Antimicrob Agents Chemother 10: 421
3. Bergan T 1977 Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine, after intravenous administration. Chemotherapy 23: 389
4. Brisson AM, Fourtillan JB 1981 Determination of cephalosporins in biological material by reversed-phase liquid column chromatography. J Chromatogr 223: 393-399
5. Brisson AM, Fourtillan JB, Barthes D, Courtois Ph, Becq-Giraudon B 1980 Comparative human pharmacokinetics of cefazolin and cefoxitin using high-performance liquid chromatography. Thérapie 35: 209
6. Committee for Proprietary Medicinal Products (CPMP) 1998 Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98, London
7. Chow S, Liu P 1992 Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Decker, New York
8. Foord RD 1976 Cefuroxime: human pharmacokinetics. Antimicrob Agents Chemother 9: 741-747
9. Gelman CR, Rumakc BH, Hutchinson TA 1999a Product information: Ceftin, cefuroxime axetil. Glaxo Inc., Research Triangle Park, NC, USA, DRUGEX system. Micromedex Inc. Englewood, CO, USA
10. Gelman CR, Rumakc BH, Hutchinson TA 1999b Product information: Zinacef, cefuroxime, Glaxo Pharmaceuticals, Research Triangle Park, NC, USA, DRUGEX system. Micromedex Inc., Englewood, CO, USA
11. Gilman AG, Goodman LS, Rall TW, Gerald L, Mandell WAA, Petri J 1985 Goodman and Gilman's The Pharmacological Basis of Therapeutics (7th edn). Macmillan, New York
12. Griffith RS, Black HR, Brier GL, Wolny D 1976 Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother 10: 814
13. Hauschke D, Steinijans VW, Diletti E 1990 A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 72-78
14. Hekster YA, Baars AM, Vree TB, van Klingeren B, Rutgers A 1980 Comparison of high-performance liquid chromatography and microbiological assay in the determination of plasma cefuroxime concentrations in rabbits. J Antimicrob Chemother 6: 65-71
15. Kirby WMM, Regamey C 1973 Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128 (Suppl): 341
16. Lecaillon JB, Rouan MC, Souppart C, Febvre N, Juge F 1982 Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography. J Chromatogr 228: 257-267
17. Lüthy R, Munch J, Bhend H, Siegenthaler W 1979 Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob Agents Chemother 16: 127
18. Nilsson-Ehle I, Nilsson-Ehle P 1979 Pharmacokinetics of cephalothin: accumulation of deacetylated metabolite in uremic patients. J Infect Dis 139: 712-716
19. Rosseel MT, Peleman R, Van Hoorebeke H, Pauwels RA 1997 Measurement of cefuroxime in human bronchoalveolar lavage fluid by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Biomed Sci 21: 438-441
20. Sanders CA, Moore ES 1986 Liquid-chromatographic assay of cefuroxime in plasma. Clin Chem 32: 2109
21. Wold JS 1977 Rapid analysis of cefazolin in serum by high-pressure liquid chromatography. Antimicrob Agents Chemother 11: 105
22. Wold JS, Turnispeed SA 1977 The simultaneous quantitative determination of cephalothin and cefazolin in serum by high pressure liquid chromatography. Clin Chim Acta 78: 203